Outcome of surgically resected thymic carcinoma: A multicenter experience

Lung Cancer

Volumn 83, Issue 2, 2014, Pages 205-210

  Filosso, Pier Luigi ^a   Guerrera, Francesco ^a   Rendina, Angelo Erino ^b   Bora, Giulia ^a   Ruffini, Enrico ^a   Novero, Domenico ^c   Ruco, Luigi ^b   Vitolo, Domenico ^d   Anile, Marco ^d   Ibrahim, Mohsen ^b   Casadio, Caterina ^e   Rena, Ottavio ^e   Terzi, Alberto ^f   Lyberis, Paraskevas ^a   Oliaro, Alberto ^a   Venuta, Federico ^d  

^a UNIVERSITY OF TURIN   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^f S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

Masaoka staging system; Myasthenia Gravis; Outcome; Surgery; Thymic carcinoma; Thymus

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CONTROLLED STUDY; HUMAN; INDUCTION CHEMOTHERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; THORAX SURGERY; THYMUS CANCER; TUMOR BIOPSY; TUMOR INVASION; TUMOR RECURRENCE;

MASAOKA STAGING SYSTEM; MYASTHENIA GRAVIS; OUTCOME; SURGERY; THYMIC CARCINOMA; THYMUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; COMBINED MODALITY THERAPY; FEMALE; HOSPITALS, SPECIAL; HUMANS; ITALY; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; STERNOTOMY; SURVIVAL ANALYSIS; THORACIC SURGERY; THYMUS NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84892892272     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.11.015     Document Type: Article

References (23)

1. Detterbeck F., Parson A.M. Thymic tumors. Ann Thorac Surg 2004, 77:1860-1869.
2. Venuta F., Anile M., Diso D., Vitolo D., Rendina E.A., De Giacomo T., et al. Thymoma and thymic carcinoma. Eur J Cardiothorac Surg 2010, 37:13-25.
3. Tseng Y.L., Wang S.T., Wu M.H., Lin M.Y., Lai W.W., Cheng F.F. Thymic carcinoma: involvement of great vessels indicates poor prognosis. Ann Thorac Surg 2003, 76:1041-1045.
4. Kondo K., Monden Y. Therapy for thymic epithelial tumors: a clinical study on 1,320 patients from Japan. Ann Thorac Surg 2003, 76:878-885.
5. Huang J., Detterbeck F.C., Wang Z., Loehrer P.J. Standard outcomes measures for thymic malignancies. J Thorac Oncol 2010, 6:S1691-S1697.
6. Marx A., Strobel P., Zettl A., chan J.K.C., Harris N.L., Kuo T.T. Thymomas. Pathology and genetics of tumours of the lung, thymus and heart 2004, 152-153. IARC Press, Lyon, [World Health Organization classification of tumours]. W.D. Travis, E. Brambilla, H.K. Muller-Hermelink, C.C. Harris (Eds.).
7. Koga K., Matsuno Y., Noguchi M., Mukai K., Asamura H., Goya T., et al. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 1994, 44:359-367.
8. Yano M., Sasaki H., Yokoyama T., Yukie H., Kawano O., Suzuki S., et al. Thymic carcinoma: 30 cases at a single institution. J Thorac Oncol 2008, 3:265-269.
9. Okereke I.C., Kesler K.A., Freeman R.K., Rieger K.M., Birdas T.J., Ascioti A.J., et al. Thymic carcinoma: outcomes after surgical resection. Ann Thorac Surg 2012, 93:1668-1673.
10. Weksler B., Dhupar R., Parikh V., Nason K.S., Pennathur A., Ferson P.F. Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients. Ann Thorac Surg 2013, 95(1):299-303. 10.1016/j.athoracsur.2012.09.006.
11. Suster S., Rosai J. Thymic carcinoma: a clinicopathologic study of 60 patients. Cancer 1991, 67:1025-1032.
12. Weissferdt A., Moran C.A. Thymic Carcinoma, part 1. A clinicopathologic and immunohistochemical study of 65 cases. Am J Clin Pathol 2012, 138:103-114.
13. Regnard J.F., Magdeleinat P., Dromer C., Dulmet E., de Montpreville V., Levi J.F., et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 1996, 112:376-384.
14. Ruffini E., Filosso P.L., Mossetti C., Bruna M.C., Novero D., Lista P., et al. Thymoma: inter-relationships among World Health Organization histology, Masaoka staging and myasthenia gravis and their independent prognostic significance: a single-centre experience. Eur J Cardiothorac Surg 2011, 40:146-153.
15. Gartner L.A., Voorhess M.L. Adrenocorticotropic hormone producing thymic carcinoid in a teenager. Cancer 1992, 71:106-111.
16. Liu H.C., Hsu W.H., Chen Y.J., Chan Y.J., Wu Y.C., Huang B.S., et al. Primary thymic carcinoma. Ann Thorac Surg 2002, 73:1076-1080.
17. Blumberg D., Burt M.E., Bains M.S., Downey R.J., Martini N., Rusch V., et al. Thymic carcinoma: current staging does not predict prognosis. J Thorac Cardiovasc Surg 1998, 115:303-308.
18. Tsuchiya R., Koga K., Matsuno Y., Mukai K., Shimosato Y. Thymic carcinoma: proposal for pathological TNM and staging. Pathol Int 1994, 44:505-512.
19. Nakamura Y., Kunitoh H., Kubota K., Sekine I., Shinkai T., Tamura T., et al. Platinum-based chemotherapy with or without thoracic radiation therapy in patients with unresectable thymic carcinoma. Jpn J Clin Oncol 2000, 30:385-388.
20. Giaccone G., Ardizzoni A., Kirkpatrick A., Clerico M., Sahmoud T., van Zandwijk N. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 1996, 14:814-820.
21. Okumura M., Miyoshi S., Takeuchi Y., Yoon H.E., Minami M., Takeda S.I., et al. Results of surgical treatment of thymomas with special reference to the involved organs. J Thorac Cardiovasc Surg 1999, 117:605-613.
22. Moran C.A., Suster S. Neuroendocrine carcinomas (carcinoid tumor) of the thymus: a clinicopathologic analysis of 80 cases. Am J Clin Pathol 2000, 114:100-110.
23. Ruffini E., Oliaro A., Novero D., Campisi P., Filosso P.L. Neuroendocrine tumors of the thymus. Thorac Surg Clin 2011, 21:13-24.